Lam Research Corp (LRCX) Misses Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts LRCX Hot Sheet
Price: $341.75 +4.80%
Financial Fact:
Operating income (loss): 315.95M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Operating income (loss): 315.95M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Lam Research Corp (NASDAQ: LRCX) reported Q3 EPS of $0.58, $0.07 worse than the analyst estimate of $0.65. Revenue for the quarter came in at $680.44 million versus the consensus estimate of $670.9 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lam Research (LRCX) PT Raised to $385 at Bernstein SocGen Group
- CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
- Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
